News

In the ever-evolving landscape of clinical trials, eConsent emerges as a revolutionary tool 🛠️, enhancing participants' comprehension and engagement with study materials. However, its adoption on a global scale faces hurdles, primarily due to widespread misconceptions. Today, let's debunk one of the most prevalent myths that may be hindering your journey towards more efficient, participant-friendly clinical processes.

🔍 Common Myth:
"My country's regulations make it impossible to implement eConsent because they necessitate a qualified electronic signature."

✅ The Truth: eConsent is designed to adapt to your specific needs, including compliance with local regulations. With PharmaTrail's secure eConsent solution, you're empowered to provide IRB-approved study information digitally. Should regulations require, participants can affix their signatures on paper. This hybrid approach ensures you reap the benefits of digital consent without compromising on compliance.

PharmaTrail's eConsent platform is crafted with flexibility at its core 🌟, allowing you to choose the most appropriate consent method—be it an electronic signature or the traditional paper format—on a per participant and Informed Consent Form basis. Our solution not only simplifies the consent process but also aligns with global regulatory standards, ensuring your clinical trials are both efficient and compliant.

🤝 Embrace the future of participant engagement in clinical trials with PharmaTrail's secure eConsent solution. Break free from misconceptions and join the growing number of professionals who are streamlining their processes, enhancing participant understanding, and adhering to regulatory requirements with ease.

One of the EFGCP eConsent initiative´s goals is to foster common eConsent terminologies to enrich communication and understanding across all stakeholders.
We are proud to support this initiative as a co-lead of the library workstream with our business and technical expertise!

Check out the newest joint article published on Applied Clinical Trials Magazine:
https://www.appliedclinicaltrialsonline.com/view/econsent-why-language-matters

Want to dive deeper?
Have a look at the glossary document itself if you want to learn more about types of digital features as well as key platform and operational aspects:
https://efgcp.eu/econsent-folder?access=Why-Language-Matters

As 2023 draws to a close, we at PharmaTrail are filled with gratitude and excitement. It's been a transformative year, marked by significant milestones and growth, all of which wouldn't have been possible without our exceptional team and valued collaboration partners. As we step into 2024, we're enthusiastic about the new challenges and opportunities that await.

We are excited to announce the initiation of the pilot phase for our electronic Clinical Outcome Assessment (eCOA) module together with the esteemed McGuire Institute!

This milestone represents a significant leap forward in the development of our cutting-edge solution.

We are thrilled to announce that we are strengthening our team with product management industry experts.

These new hires will play a pivotal role in driving innovation, bringing invaluable know-how, expertise, and fresh perspectives to further propel PharmaTrail´s growth.

We are excited to announce the successful first closing of our A2 financing round!

This will allow us to accelerate our developments towards a full product suite that will help to better serve patients, sites, sponsors and regulatory agencies.

We are grateful to have the support of a strong group of investors who share PharmaTrail’s vision and the potential of blockchain as the new standard for ensuring data security, integrity, and transparancy in clinical trials.

Our eConsent pilot study has concluded successfully! We would like to express our sincere gratitude to the clinical trial sites and participants for the time and dedication in testing as well as our partner BioValeo for all their support. Their valuable feedback will be instrumental in helping us improve our software and provide the best user experience possible!

We are thrilled to announce that our eConsent pilot study has been started successfully together with our partner BioValeo. Our blockchain-based platform is now working under real-life conditions!

We are happy to announce that our team is growing with two highly talented new members.

Damian Schraube joined the PharmaTrail team as Head of Product Management. Damian brings with him >15 years of experience in clinical trials and clinical trial IT systems both within CROs and Pharma companies. With his unique expertise we are convinced that Damian will help PharmaTrail to develop software that will be real assets to our customers. We are excited to have Damian on the PharmaTrail team.

Jonas Placzek has joined the PharmaTrail team as Junior Product Manager. Jonas did his Bachelor in medical computer science and his thesis with PharmaTrail last year. As a passionist about UI/UX we are looking forward to his contribution to PharmaTrail’s Clinical Trial Suite and are convinced that he will enable PharmaTrail to provide superior solutions to our customers.